期刊文献+

司天麦门冬汤联合化疗治疗气阴两虚型中晚期非小细胞肺癌临床观察 被引量:3

Clinical observation of Sitian Maimendong decoction and chemotherapy on middle and advanced NSCLC with qi-yin both deficiency syndrome
下载PDF
导出
摘要 目的:观察司天麦冬汤配合化疗治疗气阴两虚型Ⅲ~Ⅳ期非小细胞肺癌(NSCLC)的临床疗效。方法:选取符合纳入标准的气阴两虚证Ⅲ~Ⅳ期肺癌患者60例,随机分为两组各30例。对照组予以规范化疗;治疗组在对照组基础上口服司天麦冬汤治疗。记录两组治疗前后中医症状、卡氏功能状态评分、体重等信息以及治疗中出现的各种不良反应。21天为1个疗程,2个疗程结束后评价疗效。结果:治疗组乏力、口干咽干、自汗盗汗、失眠等中医症状以及生活质量改善情况优于对照组(P<0.05);治疗组白细胞减少、血小板减少、恶心呕吐、肾功能损伤发生率低于对照组(P<0.05)。结论:司天麦冬汤联合化疗能提高气阴两虚证肺癌的临床疗效,并在一定发程度上减轻毒副反应。 Objective:To observe the clinical efficacy of Sitian Maimendong decoction and chemotherapy on Ⅲ~Ⅳ stage NSCLC with qi-yin both deficiency syndrome.Methods:60 cases of selected patients with Ⅲ~Ⅳ stage lung cancer with qi-yin both deficiency syndrome,who met the inclusion criteria,were randomly divided into two groups,30 cases in each group.The control group was treated by standardized chemotherapy,while the treatment group was treated with oral Sitian Maimendong decoction on the basis of control group.TCM symptoms,Karnofsky performance status score,body weight and other informations as well as various adverse reactions during treatment were recorded in two groups before and after treatment.21 days as a course of treatment.The clinical efficacy was evaluated after 2 courses of treatment.Results:In the treatment group,the improvement of TCM symptoms such as fatigue,dry mouth and dry pharynx,spontaneous sweating and night sweating,insomnia,etc.as well as quality of life were better than in control group(P < 0.05).Leukopenia,thrombocytopenia,nausea-vomiting and incidence of renal dysfunction in treatment group were lower than in control group(P<0.05).Conclusion:Sitian Maimendong decoction and chemotherapy can enhance the clinical effect on lung cancer with qi-yin both deficiency syndrome,and reduce the toxic and side effects to a certain extent.
作者 柳为 张东伟 LIU Wei;ZHANG Dong-wei(Graduate School,Anhui University of Traditional Chinese Medicine,Hefei 230000,China;不详)
出处 《山西中医》 2021年第12期25-27,35,共4页 Shanxi Journal of Traditional Chinese Medicine
关键词 肺恶性肿瘤 气阴两虚 化疗 司天麦冬汤 中西医结合疗法 lung malignant tumor qi-yin both deficiency chemotherapy Sitian Maimendong decoction therapy of traditional Chinese and western medicine
  • 相关文献

参考文献9

二级参考文献46

  • 1耿计伟,姬建丽,肖斌.靶向药物联合化疗应用于晚期非小细胞肺癌临床治疗[J].智慧健康,2020(21):96-97. 被引量:4
  • 2王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:625
  • 3吴一龙,蒋国梁,廖美琳,周清华,陆舜,王绿化,张力,无.非小细胞肺癌孤立性转移处理共识[J].循证医学,2007,7(2):109-111. 被引量:21
  • 4Ram i-Porta R, Bolejack V , Crowley J , et al. The IASLC LungCancer Staging P roject: Proposals for the Revisions of the TDescriptors in the Forthcom ing Eighth Edition of the TN MClassification for Lung Cancer [J] . J Thorac Oncol, 2015, 10( 7 ) :990-1003. 被引量:1
  • 5Asam ura II, Chansky K, Crowley J , et al. The InternationalAssociation for the Study of Lung Cancer Lung Cancer StagingProject : Proposals for the Revision of the N Descriptors in theForthcom ing 8th Edition of the TN M Classification for LungCancer [J] . J Thorac Oncol 2015,10(12) : 1675-1684. 被引量:1
  • 6E berhardt W E, M itchell AM , Crowley J, et al. The IASLCLung Cancer Staging P roject: Proposals for the Revisions of theM Descriptors in the Forthcom ing Eighth Edition of the TN MClassification for Lung Cancer [J] . J Thorac Oncol, 2015, 10(11) :1515-1522. 被引量:1
  • 7International Association for the Study of Lung Cancer. StagingM anual in Thoracic Oncology [M] . 2009. 被引量:1
  • 8Ram i-Porta R, Goldstraw P. Strength and weakness of the newT N M classification for lung cancer [J] . Eur Respir J, 2010,36( 2 ) :237-239. 被引量:1
  • 9Ram i-Porta R, Bolejack V , Giroux D J, et al. The IASLC lungcancer staging project: the new database to inform the eighthedition of the TN M classification of lung cancer [J] . J ThoracOncol, 2 0 1 4 ,9 (1 1 ):1618-1624. 被引量:1
  • 10De Ruysscher D, W anders R, van Baardwijk A , et al. Radicaltreatm ent of non-small-cell lung cancer patients w ithsynchronous oligom etastases: long-term results of a prospectivephase 11 trial (N ct01282450) [J] . J Thorac Oncol, 2 0 1 2,7(10):1547-1555. 被引量:1

共引文献235

同被引文献112

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部